CONFIRMEDDate confidence: CONFIRMEDStated as firmHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all CONFIRMED pins84% CONFIDENCEOverall confidence: 84%How well the pin's source and references back up its dates.Weighted average of how firmly 4 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or betterAbbVie's[1] release is titled 'AbbVie Reports Second-Quarter 2026 Financial Results' and dated July 31, 2026.
AbbVie reported second-quarter 2026 net revenues of US$16.990 billion, up 10.2 percent, with Skyrizi at US$5.505 billion, Rinvoq at US$2.525 billion and Humira down to US$756 million.
1.00